Federal grants to The Translational Genomics Research Institute
The Translational Genomics Research Institute in Phoenix, Arizona received $29.1 million in federal grants from fiscal 2021 to 2025, across 23 awards. Its largest program was Diabetes, Digestive, and Kidney Diseases Extramural Research, with $7.8 million. In fiscal 2025 it was awarded $5.1 million.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$29.1 million
- Awards23
- Awarded in FY 2025$5.1 million
- Largest award$3.8 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 9 | $3.6 million |
| FY 2022 | 10 | $5.3 million |
| FY 2023 | 11 | $9.7 million |
| FY 2024 | 8 | $5.5 million |
| FY 2025 | 9 | $5.1 million |
Programs that fund The Translational Genomics Research Institute
| Program | Awards | Amount |
|---|---|---|
| Diabetes, Digestive, and Kidney Diseases Extramural Research | 3 | $7.8 million |
| Cardiovascular Diseases Research | 1 | $3.8 million |
| Aging Research | 3 | $3.6 million |
| Allergy and Infectious Diseases Research | 4 | $3.5 million |
| Human Genome Research | 1 | $2.9 million |
| Extramural Research Programs in the Neurosciences and Neurological Disorders | 2 | $2.8 million |
| Military Medical Research and Development | 3 | $2.1 million |
| Animal Disease and Animal Care | 1 | $1.3 million |
| Cancer Cause and Prevention Research | 1 | $737,014 |
| Cancer Treatment Research | 1 | $269,280 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 19 | $25.7 million |
| Department of Defense | 3 | $2.1 million |
| Department of Agriculture | 1 | $1.3 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Combining genome, function, and phenotype to define the cell type specific gene regulatory architecture of idiopathic pulmonary fibrosis | Cardiovascular Diseases Research | December 31, 2020 | $3.8 million |
| Integrative omics to enhance therapeutics development for healthy aging - abstract/summary a number of drugs and interventions have been identified that curb morbidities associated with individual age- related diseases, and a few compounds have been identified that increase longevity in mice and oth | Aging Research | August 26, 2021 | $3.5 million |
| Extracellular vesicle cargo and risk of nafld and nash in latino youth - project summary/abstract the prevalence of pediatric nonalcoholic fatty liver disease (NAFLD) is escalating in us youth, particularly in those of latino ancestry. Nafld in children is associated with poor long-term outcomes, in | Diabetes, Digestive, and Kidney Diseases Extramural Research | April 12, 2022 | $3.2 million |
| Integrated analysis of multi-omic qtls at single cell resolution - project summary novel statistical and computational tools have enabled the broad adoption of genomics technologies and served as the foundation for the modern age of human genomics. Indeed, the recent advent and popularity of single | Human Genome Research | September 15, 2022 | $2.9 million |
| High-resolution, virome-wide infection analysis in type 1 diabetes birth cohorts - project abstract/summary type 1 diabetes (T1D) affects >20 million people globally, causing life-long dependency on exogenous insulin and reduced life expectancy. Although the disease has a strong genetic basis, a sub | Diabetes, Digestive, and Kidney Diseases Extramural Research | May 31, 2024 | $2.5 million |
| A scalable platform for highly-multiplexed analysis of antibody reactivity from <1UL of blood | Allergy and Infectious Diseases Research | April 9, 2021 | $2.4 million |
| A large-scale extracellular vesicle rna-seq resource for parkinsons disease - project summary/abstract parkinson's disease (PD) is a devastating and progressive neurological disease that impacts 6 million people worldwide. The lack of validated biomarkers of pd has hampered improvements in predictin | Extramural Research Programs in the Neurosciences and Neurological Disorders | May 19, 2023 | $2.3 million |
| Profiling extracellular vesicle cargo in obesity and type 2 diabetes | Diabetes, Digestive, and Kidney Diseases Extramural Research | July 29, 2021 | $2.2 million |
| Genomic dissection of structural mutations following telomere dysfunction in glioblastoma cells and patients | Military Medical Research and Development | July 31, 2023 | $1.5 million |
| The purpose of this award is to address gaps in surveillance and investigation activities for SARS-COV-2 in animals, including farmed animals, captive wildlife, free-ranging wildlife, and companion animals.this work aims to enhance surveillance for SARS-COV-2 in dogs to characterize these risk facto | Animal Disease and Animal Care | May 17, 2023 | $1.3 million |
Questions people ask
How much federal grant money does The Translational Genomics Research Institute get?
$29.1 million in 23 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives The Translational Genomics Research Institute the most?
The Department of Health and Human Services, with $25.7 million in 19 awards. The Department of Defense and the Department of Agriculture follow.
What is The Translational Genomics Research Institute's largest federal grant?
$3.8 million under Cardiovascular Diseases Research, with its first action in the period on December 31, 2020. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund The Translational Genomics Research Institute?
Its largest are Diabetes, Digestive, and Kidney Diseases Extramural Research, Cardiovascular Diseases Research and Aging Research.
Other grant recipients in Phoenix
- Arizona Health Care Cost Containment System
- Arizona Department of Education
- Arizona Department of Economic Security
- Department of Transportation Arizona
- Arizona Department of Health Services
- City of Phoenix
- Arizona Commerce Authority
- Arizona Department of Emergency & Military Affairs
Largest federal grant recipients in Arizona · Federal grants in Arizona